Delivery Order SPE2DR25D1202-SPE2DR26F72SS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets (100-count packages) valued at $1,252.50. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract specifies September 29, 2025, as the ultimate completion date, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract ceiling value of $3,665.97. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is set for May 21, 2025, and performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets in quantities of 100 units, with a contract ceiling value of $27,644.83. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by November 10, 2025, and will be performed at the contractor's Corporate Office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Atovaquone-Proguanil 250-100 in quantities of 100 tablets. This non-set-aside delivery order has a ceiling value of $3,443.12 and firm fixed pricing, with an ultimate completion date of December 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Atovaquone-Proguanil 250-100 in a quantity of 100 units, with a ceiling value of $4,882.70. This award utilized firm fixed price pricing and is classified as a non-set-aside competitive procurement. The delivery order is contingent upon completion by August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,248.56 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100-count supply). The contract, which is firm fixed price with no set-aside designation, was awarded on August 18, 2025, and is scheduled for completion by August 19, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.20 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atovaquone-Proguanil 250-100 (100 tablets). This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the award was competitively procured. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,044.48 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This firm fixed-price delivery order is non-set-aside and scheduled for ultimate completion by November 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication will support military and federal healthcare requirements through the agency's...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72SSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units. Valued at $2,510.21 with a firm fixed price structure, this non-set-aside delivery order is scheduled for completion by December 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement to support federal medical supply needs, consistent with the Defense Logistics Agency's critical role in supplying medications and medical commodities to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen Drug Corp maintains one of the largest federal contracts for global pharmaceutical support, enabling the company to supply an extensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contractor's competitively awarded contracts and demonstrated capability to fulfill federal procurement requirements underscore its position as a critical supplier within the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/2/25 |